Another CPT1 inhibitor, ST1326, prevented formation of B-cell lymphoma in mice (177) and CPT1 inhibitor ranolazine administered together with pyruvate dehydrogenase kinase inhibitor DCA inhibited growth of glioblastoma in mice (178). This evidence concerns the gene CPT1A and B-cell non-Hodgkin lymphoma.